Quest Diagnostics (DGX) Income from Non-Controlling Interests (2009 - 2026)
Quest Diagnostics' (DGX) quarterly Income from Non-Controlling Interests came in at $14.0 million in Q2 2026, little changed year-over-year from $14.0 million in Q2 2025, and up 16.67% quarter-over-quarter from $12.0 million in Q1 2026.
Analysis
Quest Diagnostics (DGX) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Quest Diagnostics has disclosed Income from Non-Controlling Interests across 18 years of filings, most recently posting $14.0 million for Q2 2026.
- In Q2 2026, Income from Non-Controlling Interests changed 0.0% year-over-year to $14.0 million; the TTM figure through Jun 2026 stood at $51.0 million (down 5.56% YoY), while the FY2025 annual figure was $54.0 million, up 8.0% from the prior year.
- Income from Non-Controlling Interests came in at $14.0 million for Q2 2026 at Quest Diagnostics, up from $12.0 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $20.0 million in Q3 2022 to a low of $11.0 million in Q2 2024.
- Average Income from Non-Controlling Interests over 5 years is $14.1 million, with a median of $14.0 million recorded in 2023.
- Year-over-year, Income from Non-Controlling Interests slumped 40.0% in 2023 and grew 27.27% in 2025.
- Over 5 years, Income from Non-Controlling Interests stood at $15.0 million in 2022, then slipped by 13.33% to $13.0 million in 2023, then grew by 7.69% to $14.0 million in 2024, then retreated by 21.43% to $11.0 million in 2025, then gained by 27.27% to $14.0 million in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $14.0 million in Q2 2026, $12.0 million in Q1 2026, and $11.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 14.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 400,000.00 |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -153,000.00 |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.00 Mn |
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 11.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Sep 30, 2023 | 12.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 15.00 Mn |
| Dec 31, 2022 | 15.00 Mn |
| Sep 30, 2022 | 20.00 Mn |
| Jun 30, 2022 | 16.00 Mn |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 23.00 Mn |
| Sep 30, 2021 | 22.00 Mn |